There were 1,544 press releases posted in the last 24 hours and 394,390 in the last 365 days.
For Immediate Release: June 09, 2022 Today, the U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula available in the U.S. under the agency’s recent increased flexibilities. Company …
FDA News Release Agency remains committed to updating public about Philips recalled devices For Immediate Release: September 06, 2022 Today, the U.S. Food and Drug Administration is alerting patients, caregivers and health care providers that Philips …
For Immediate Release: September 06, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA published the 2022: Advancing Regulatory Science at FDA: Focus Areas of Regulatory …
FDA News Release Next Legends Campaign Aims to Educate Native American Youth About Harms of Vaping through Culturally Specific Ads For Immediate Release: June 08, 2022 Today, the U.S. Food and Drug Administration announced the launch of the “Next Legends” …
For Immediate Release: June 07, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA announced it is considering a master file pilot program for premarket approval (PMA) …
For Immediate Release: July 06, 2022 Statement From: Robert M. Califf, M.D., MACC Commissioner of Food and Drugs - Food and Drug Administration Susan T. Mayne, Ph.D. Director - Center for Food Safety and Applied Nutrition (CFSAN) The need to diversify and …
FDA News Release New Prescribing Authority Could Improve Access for Some Patients at High Risk for Severe COVID-19 For Immediate Release: July 06, 2022 Today, the U.S. Food and Drug Administration revised the Emergency Use Authorization (EUA) for Paxlovid …
For Immediate Release: July 06, 2022 Today, the U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula available in the U.S. under the agency’s recent increased flexibilities. Company …
For Immediate Release: May 31, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: The FDA’s Center for Drug Evaluation and Research (CDER), Center for Devices and Radiological Health (CDRH …
For Immediate Release: May 27, 2022 Today, the U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula on U.S. store shelves in the coming weeks and months. “We continue to work around …
For Immediate Release: May 27, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On May 26, the FDA posted warning letters to multiple companies illegally selling CBD products intended for …
For Immediate Release: May 26, 2022 Today, the U.S. Food and Drug Administration is providing an update on steps it has taken that will lead to millions of bottles of specialized medical infant formula to help address immediate needs for infants with …
For Immediate Release: May 24, 2022 Today, the U.S. Food and Drug Administration is providing an update on steps it has taken that will lead to millions of cans of additional infant and specialty formula being available to U.S. consumers. “We continue to …
For Immediate Release: May 24, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On May 23, the FDA announced the availability of one final guidance and two draft guidances for blood …
For Immediate Release: May 20, 2022 Today, the U.S. Food and Drug Administration approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in adults and pediatric patients 12 years and older weighing at least 40 kilograms (which is about 88 …
For Immediate Release: May 20, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On May 19, the FDA issued responses to two food additive petitions and a citizen petition requesting agency …
For Immediate Release: May 19, 2022 Statement From: Patrizia Cavazzoni, M.D. Director - Center for Drug Evaluation and Research Drug shortages pose a significant public health threat as they can delay, and in some cases, even deny critically needed care …
For Immediate Release: May 19, 2022 Today, the U.S. Food and Drug Administration announced the availability of a draft guidance aimed at increasing the amount of safety information the agency has about the dietary supplement marketplace by providing the …
For Immediate Release: May 17, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA published the FDA Voices: “FDA Seeks to Engage Stakeholders on Key Considerations for a Drug …
For Immediate Release: May 17, 2022 Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the use of a single booster dose for administration to individuals 5 …
